Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors (XMT-1107)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Mersana Therapeutics
ClinicalTrials.gov Identifier:
NCT01011972
First received: November 10, 2009
Last updated: September 19, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2013
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)